Board of Visitors Grants $1.7 Million to Advance Immunotherapy and Epilepsy Care

The Board of Visitors of Children’s National has awarded $1.7 million in grants to support vital research programs – epilepsy and molecular and cellular immunotherapy.

Dr. Catherine Bollard, Chief of Allergy and Immunology, and Dr. Yang Liu, Director, Center for Cancer and Immunology Research, will use a $1.5 million grant from the Board of Visitors to support pilot research projects for new treatments for children with cancer, immune disorders, and serious infections.

The Board of Visitors also awarded $200,000 to Dr. William Gaillard, Division Chief of Epilepsy and Neurophysiology and Chief of Child Neurology, to support his work to enhance treatment opportunities for children with epilepsy through advanced imaging acquisition and analysis.

The projects were selected through a highly competitive application process open to clinician scientists throughout Children’s National. The Board of Visitors, which has supported Children’s National for nearly 150 years, raises money though its signature events -- A Vintage Affair and the sale of Care for Kids cards. In addition to supporting initiatives through its annual grants program, the Board of Visitors has provided major gifts to support the Board of Visitors Simulation Program, Seacrest Studios, the Board of Visitors Cerebral Palsy Prevention Program, the PANDA Palliative Care Team, the purchase of a mass spectrometer for the Center for Genetic Medicine Research, the Personalized Pediatric Cancer Research Program, and the William and Joanne Conway Chair in Nursing Research.

Learn more about the Board of Visitors, their campaigns, and their impact.